| (HKD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 574.12M | -41.46% |
| Operating expense | — | — |
| Net income | -1.24B | 206.53% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 6855.HK returned -63.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -36.7% |
| 1 year | -63.3% |
| 5 years | -13.8% |
| All-time high | $83.15 (Aug 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 6855.HK would be worth today ›No. Ascentage Pharma Group International has not paid a dividend in the past 12 months.
Ascentage Pharma Group International is part of the Healthcare sector.
Ascentage Pharma Group International has a market cap of 12.43B HKD, based on the latest quote.
